Statistics for Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition
Total visits
| views | |
|---|---|
| Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition | 0 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:a304e8da-35e6-4e64-87cd-3bbb9c3816b7 | 15 |
| java.util.UUID:54e03a4c-f163-4e3d-9690-d36690debd73 | 13 |
| DuBose2024Neratinib-CCBY.pdf | 7 |
| java.util.UUID:3da41e5e-7ab1-4e0b-9a82-514b2eff7315 | 2 |